1. Home
  2. NMRA vs JUNS Comparison

NMRA vs JUNS Comparison

Compare NMRA & JUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • JUNS
  • Stock Information
  • Founded
  • NMRA 2019
  • JUNS 2015
  • Country
  • NMRA United States
  • JUNS United States
  • Employees
  • NMRA N/A
  • JUNS N/A
  • Industry
  • NMRA
  • JUNS
  • Sector
  • NMRA
  • JUNS
  • Exchange
  • NMRA Nasdaq
  • JUNS NYSE
  • Market Cap
  • NMRA 287.6M
  • JUNS 281.4M
  • IPO Year
  • NMRA 2023
  • JUNS 2024
  • Fundamental
  • Price
  • NMRA $1.15
  • JUNS $0.75
  • Analyst Decision
  • NMRA Buy
  • JUNS
  • Analyst Count
  • NMRA 8
  • JUNS 0
  • Target Price
  • NMRA $10.14
  • JUNS N/A
  • AVG Volume (30 Days)
  • NMRA 1.3M
  • JUNS 134.9K
  • Earning Date
  • NMRA 03-03-2025
  • JUNS 05-11-2025
  • Dividend Yield
  • NMRA N/A
  • JUNS N/A
  • EPS Growth
  • NMRA N/A
  • JUNS N/A
  • EPS
  • NMRA N/A
  • JUNS N/A
  • Revenue
  • NMRA N/A
  • JUNS N/A
  • Revenue This Year
  • NMRA N/A
  • JUNS N/A
  • Revenue Next Year
  • NMRA N/A
  • JUNS N/A
  • P/E Ratio
  • NMRA N/A
  • JUNS N/A
  • Revenue Growth
  • NMRA N/A
  • JUNS N/A
  • 52 Week Low
  • NMRA $1.12
  • JUNS $0.55
  • 52 Week High
  • NMRA $17.19
  • JUNS $19.51
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 30.06
  • JUNS N/A
  • Support Level
  • NMRA $1.12
  • JUNS N/A
  • Resistance Level
  • NMRA $1.23
  • JUNS N/A
  • Average True Range (ATR)
  • NMRA 0.11
  • JUNS 0.00
  • MACD
  • NMRA 0.05
  • JUNS 0.00
  • Stochastic Oscillator
  • NMRA 14.15
  • JUNS 0.00

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

About JUNS JUPITER NEUROSCIENCES INC

Jupiter Neurosciences Inc is a clinical stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a unique resveratrol platform product primarily targeting treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to most central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.

Share on Social Networks: